Teniposide Injection
BRIEFING
Teniposide Injection. This proposal is based on the version of the monograph official as of May 1, 2018. It is proposed to omit this monograph for the following reasons:
-
No drug products formulated as defined under Teniposide Injection are currently marketed in the United States.
-
The drug product is currently not on the list for approved veterinary medicine in the United States.
(SM3: N. Myers)
Correspondence Number—C326114
USP REFERENCE STANDARDS FOR PURCHASE
USP Benzaldehyde RSUSP Teniposide RS
USP Teniposide Related Compound A RS